Bifidobakterium dan Kesehatan Saluran Cerna Anak

Reza Ranuh, Badriul Hegar


Kolonosisasi mikrobiota saluran cerna yang didominasi oleh mikrobiota sehat merupakan aspek penting dalam optimalisasi kesehatan anak. Komposisi mikrobiota saluran cerna selalu berubah pada setiap keadaan karena banyak faktor yang memengaruhinya. Bifidobacteria terdapat dalam Air Susu Ibu dan mendominasi saluran cerna bayi yang mendapat ASI eksklusif, seringkali dikaitkan dengan kesehatan bayi dan anak dikemudian hari. Bifidobacteria dikategorikan dalam dua kelompok, yaitu (1) spesies Bifidobacteria berasal dari manusia (human residential bifidobacteria/HRB) dan (2) spesies Bifidobacteria yang secara alami berkoloni di hewan/ lingkungan (non-HRB). Bifidobacteria breve, B. longum subsp.infantis, dan B. bifidum adalah HRB yang terdapat pada bayi. Kolonisasi usus bayi ASI eksklusif didominasi oleh HRB saat berusia 2 minggu. Suplementasi HRB memberikan efek protektif NEC pada bayi dengan usia gestasi <34 minggu. Resolusi sakit perut bermakna terlihat pada irritable bowel syndrome yang mendapat suplementasi HRB, walaupun demikian belum cukup kuat bukti untuk menyatakan bahwa probiotik lebih efektif dalam mencegah kolik infantil.

Kata Kunci

mikrobiota; saluran cerna; ASI

Teks Lengkap:



Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J, dkk. The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol Mol Biol Rev 2017;81:3–13.

Vandenplas Y, Ludwig T, Szajewska H . Gut health in early life: implications and management of gastrointestinal disorders. London: John Wiley and Sons; 2015.

Carabottia M, Sciroccoa A, Masellib MA, Severia C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 2015;28:203-9.

Perez PF, Dore J, Leclerc M, dkk. Bacterial imprinting of neonatal immune system: lesson from maternal cells? Pediatrics 2007;119:e724-32.

Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, dkk. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 2000;30:61-7.

Nagpal R, Kurakawa T, Tsuji H, dkk. Evolution of gut Bifidobacterium population in healthy Japanese infants over the first three years of life: a quantitative assessment. Sci Rep 2017;7:10097 -108.

Matamoros S, Gras-Leguen C, Le Vacon F, Potel G, de La Cochetiere MF. Development of intestinal microbiota in infants and its impact on health. Trends Microbiol 2013;21:167-73

Endo A, Partty A, Kalliomaki K, Isolauri E, Salminen S. Long-term monitoring of the human intestinal microbiota from the 2nd week to 13 years of age. Anaerobe 2014;6: 149-56

Derrien M, Alvarez AS, de Vos WM. The gut microbiota in the first decade of life. Trends Microbiol 2019;27:997–1010. j.tim.2019.08.001.

Stewart CJ, Embleton ND, Clements E, dkk. Cesarean or vaginal birth does not impact the longitudinal development of the gut microbiome in a cohort of exclusively preterm infants. Front Microbiol 2017;8:1-9.

Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med 2016;22:713-22.

Tanaka M, Nakayama J. Development of the gut microbiota in infancy and its impact on health in later life. Allergol Int 2017;66:515-22

Azad MB, Konya T, Maughan H, dkk . Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ 2013;185:385-94.

Renz-Polster H, David MR, Buist AS, dkk . Caesarean section delivery and the risk of allergic disorders in childhood Clin Exp Allergy 2005;35:1466-72.

Stewart CJ, Embleton ND, Clements E, dkk . Cesarean or vaginal birth does not impact the longitudinal development of the gut microbiome in a cohort of exclusively preterm infants. Front Microbiol 2017;8:1–9.

Koletzko B, Aggett PJ, Bindels JG, Bung P, Ferré P. Growth, development and differentiation: a functional food science approach. Br J Nutr 1998;80 Suppl 1:S5-45.

Kohler H. Antibacterialcharacteristic in the feces of breast-fed and formula-fed infants during the first year of life. J Pediatr Gastroenterol Nutr 2001;34:188-93.

Mantis NJ, Rol N, Corth B. Complex roles in immunity and mucosal homeostasis in the gut. Review 2011;4:603-9.

Walter J, Ley RE. The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol 2011;65:411-29.

Gänzle MG, Follador R. Metabolism of Oligosaccharides and Starch in Lactobacilli: A Review. Front Microbiol 2012;3:340.

Cheikhyoussef A, Pogori, N, Zhang. Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application. Int J Food Microbiol 2008;125:215-22.

Andersson Y, Lindquist S, Lagerqvist C, Hernell O. Lactoferrin is responsible for the fungistatic effect of human milk. Early Hum Dev 2000;59:95-105.

Perez PF, Dore J, Leclerc M, Levenez F, Benyacoub J, Serrant P,. Bacterial imprinting of neonatal immune system : lesson from maternal cells? Pediatrics 2007;119:e724-32.

Parte AC. LPSN – list of prokaryotic names with standing in nomenclature. Nucleic Acids Res 2014;42:D613-6.

Wong CB, Sugahara H, Odamaki T, Xiao JZ. Different physiological properties of human-residential and non-human-residential bifidobacteria in human health. Benef Microbes 2018, 9:111-22.

Tannock GW, Lawley B, Munro K, dkk. Comparison of the compositions of the stool microbiotas of infants fed goat milk formula, cow milk-based formula, or breast milk. App Environ Microbiol 2013;79:3040-8.

Minami J, Odamaki T, Hashikura N, Abe F, Xiao JZ. Lysozyme in breast milk is a selection factor for bifidobacterial colonisation in the infant intestine Benef Microbes 2016;7:53-60.

Sugara H, Odamaki T, Hashikura Ndkk . Differences in folate production by bifidobacteria of different origins. Biosci Microbiota Food Health 2015;34 :87-93.

Odamaki T, Horigome A, Sugahara H, dkk. Comparative genomics revealed genetic diversity and species/strain-level differences in carbohydrate metabolism of three probiotic Bifidobacterial species. Int J Genomics 2015;2015:1-12.

O’Callaghan and van Sindaren. Bifidobacteria and their role as members of human gut microbiota : A review. Front Microbiol 2016;7:1-23.

Thongaram T, Hoeflinger JL, Chow J, Miller MJ. Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli. J Dairy Sci 2017;100:7825-33.

Abe F, Muto M, Yaeshima T, dkk. Safety evaluation of probiotic Bifidobacteria by analysis of mucin degradation activity and translocation ability. Anaerobe 2010;16:131-6.

Bennet R, Nord CE, Zetterstrom R. Transient colonization of the gut of newborn infants by orally administered bifidobacteria and lactobacilli. Acta Paediatr 1992;81:784-7.

Grzeskowiak L, Grönlund MM, Beckmann C, Salminen S, von Berg A, Isolauri E. The impact of perinatal probiotic intervention on gut microbiota: Double-blind placebo-controlled trials in Finland and Germany. Anaerobe 2012;18:7-13

Li Y, Shimizu T, Hosaka A, Kaneka N, Ohtsuka Y, Yamashiro Y. Effects of bifidobacterium breve supplementation on intestinal flora of low birth weight infants. Pediatrics Int 2004;46:509-15.

Ishizeki S, Sugita M, Takata M, Yaeshima T. Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: A comparison between one-species and three-species administration. Anaerobe 2013;23:38-44.

Jape GA, Minaee N, Nathan E, Simmer K, Patole S. Outcome in preterm small versus appropriate for gestation infants after Bifidobacterium breve M-16 supplementation. Fetal Neonatal Med 2020;33:2209-15.

Chongxin Wang, Hiromichi Shoji, Hiroaki Sato, dkk. Effects of oral administration of Bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants. J Pediatr Gastroenterol Nutr 2007;44: 252-7.

Hagen PC, Skelley JW. Efficacy of Bifidobacterium species in prevention of necrotizing enterocolitis in very-low birth weight infants. A systematic review. J Pediatr Pharmacol Ther 2019;24:10–5.

Wu BB, Yang Y, Xu X, Wang WP. Effects of Bifidobacterium supplementation on intestinal microbiota composition and the immune response in healthy infants. World J Pediatr 2016;12:177-82.

Russo M, Giugliano FP, Quitadamo P, dkk. Efficacy of a mixture of probiotic agents as complementary therapy for chronic functional constipation in childhood. Ital J Pediatr 2017;43:1-7.

Gianneti E, Maglione M, Alessandrella, A, dkk. A mixture of 3 Bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double-blind, placebo-controlled, crossover trial. Clin Gastroenterol 2017;51:e5-10.

Dale HF, Rasmussen SH, Asiller OO, Lied GA. Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review. Nutrients 2019;11:2048.

Nafarin AR, Hegar B, Sjakti HA, Vandneplas Y. Gut microbiome pattern in adolescents with functional gastrointestinal disease. J Pediatr Adolesc Med 2019;6:12-5.

de Weerth C, Fuentes S, Puylaert P, de Vos WM. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics 2013;131:550-8.

Ong TG, Gordon M, Banks SSC, Thomas MR, Akobeng AK. Probiotics to prevent infantile colic. Cochrane Database Syst Rev 2019: CD012473. doi: 10.1002/ 14651858.cd012473.pub2.

Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antiviotic-associated diarrhea. Cochrane Database Syst Rev 2019: CD004827. doi: 10.1002/14651858.CD004827.pub5.



  • Saat ini tidak ada refbacks.


Informasi Editorial:
Badan Penerbit Ikatan Dokter Anak Indonesia
Jl. Salemba I No 5, Jakarta 10430, Indonesia
Phone/Fax: +62-21-3912577
Email: editorial [at]

Lisensi Creative Commons
Sari Pediatri diterbitkan oleh Badan Penerbit Ikatan Dokter Anak Indonesia
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.